← Back to Treatments
🏅 FDA Orphan Designation

VERMOX 500 mg chewable tablets

mebendazole

Manufacturer: Janssen Pharmaceutical Research & Development, LLC

Indicated for:
Patent ductus arteriosus-bicuspid aortic valve-hand anomalies syndromeOrphanAnkylostomiasisListeriosis

FDA-Approved Indications (3)

treatment of patients one year of age and older withgastrointestinal infections caused by Ascaris lumbricoides (roundworm) and Trichuris trichiura (whipworm)

indicated for the treatment of patients one year of age and older with gastrointestinal infections caused by Ascaris lumbricoides (roundworm)

Population: pediatric ≥1 year and older

indicated for the treatment of patients one year of age and older with gastrointestinal infections caused by Trichuris trichiura (whipworm)

Population: pediatric ≥1 year and older

Indications & Usage

1 INDICATIONS AND USAGE VERMOX™ CHEWABLE is indicated for the treatment of patients one year of age and older with gastrointestinal infections caused by Ascaris lumbricoides (roundworm) and Trichuris trichiura (whipworm). VERMOX™ CHEWABLE is an anthelmintic indicated for the treatment of patients one year of age and older with gastrointestinal infections caused by: Ascaris lumbricoides (roundworm) and Trichuris trichiura (whipworm) ( 1 ).

💙 Support Programs

View all →
VERMOX 500 mg chewable tablets
Janssen Pharmaceutical Research & Development, LLC
VERMOX 500 mg chewable tablets
Janssen Pharmaceutical Research & Development, LLC

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.